Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S), Royal Australasian College of Surgeons, 199 Ward Street, North Adelaide, 5006, SA, Australia.
Support Care Cancer. 2014 Jun;22(6):1715-26. doi: 10.1007/s00520-014-2198-z. Epub 2014 Mar 29.
The purpose of this paper was to provide an evidence-based evaluation of the safety and effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of non-neurological soft tissue radiation-related injuries (STRI).
Systematic searches of medical bibliographic databases, the Internet, and lists of references were conducted in December 2010 and April 2013 to identify relevant primary studies. Inclusion and classification of papers was resolved through the application of a predetermined protocol. Information on both the safety and effectiveness of HBOT was analyzed.
Forty-one articles were included, with 11 comparing HBOT to a regimen without HBOT. Comparative evidence varied considerably in methodological quality, and numerous limitations were identified. Absolute data showed that serious adverse events after HBOT were rare, while more common adverse events were minor and self-limiting. Compared to observation, conventional, or sham therapies, evidence of benefit in clinical outcomes was shown for HBOT for radiation proctitis and wounds in irradiated soft tissue of the head and neck, but not for postirradiation soft tissue edema or radiation cystitis. Clinical outcomes differed little between HBOT and argon plasma coagulation for radiation proctitis and between HBOT and hyaluronic acid for radiation cystitis.
HBOT is a safe intervention which may offer clinical benefits to patients suffering from radiation proctitis and non-neurological STRI of the head and neck. However, differing clinical responses across STRI demonstrate a need for further well-designed clinical trials to validate the use of HBOT for individual STRI, both as an adjunct to conventional treatments and relative to definitive treatments.
本文旨在对高压氧疗法(HBOT)治疗非神经性软组织放射性损伤(STRI)的安全性和有效性进行循证评估。
系统检索了医学文献数据库、互联网和参考文献列表,以确定相关的原始研究。通过应用预定的方案解决了论文的纳入和分类问题。分析了 HBOT 的安全性和有效性信息。
共纳入 41 篇文章,其中 11 篇比较了 HBOT 与无 HBOT 方案。比较性证据在方法学质量上差异很大,并且确定了许多局限性。绝对数据表明,HBOT 后严重不良事件罕见,而更常见的不良事件是轻微且自限性的。与观察、常规或假治疗相比,HBOT 对放射性直肠炎和头颈部照射软组织伤口的临床结局有获益证据,但对放射性软组织水肿或放射性膀胱炎无获益证据。HBOT 治疗放射性直肠炎与氩等离子凝固、HBOT 治疗放射性膀胱炎与透明质酸的临床结局差异不大。
HBOT 是一种安全的干预措施,可能为放射性直肠炎和头颈部非神经性 STRI 患者带来临床获益。然而,不同的 STRI 临床反应表明,需要进一步设计良好的临床试验来验证 HBOT 对个别 STRI 的应用,无论是作为常规治疗的辅助手段还是相对于确定性治疗。